NCT05217095 is a NA clinical trial of Convergence Dialyzer in Renal Dialysis, sponsored by D.med Consulting GmbH.

Who is sponsoring NCT05217095?

NCT05217095 is sponsored by D.med Consulting GmbH.

What drugs are being tested in NCT05217095?

Interventions in NCT05217095: Convergence Dialyzer.

What condition does NCT05217095 study?

NCT05217095 studies Renal Dialysis.

Is NCT05217095 still recruiting?

NCT05217095 is currently completed. Last updated 2 March 2022.

Last reviewed 2022-03-02 · How we verify

NCT05217095

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Trial on a Novel Blood Pumping System in 4008A Hemodialysis Machine

Completed NA Last updated 2 March 2022

What this trial tests

NA trial testing Convergence Dialyzer in Renal Dialysis in 8 participants. Completed in 22 February 2022.

Timeline

19 January 2022

Primary endpoint
22 January 2022

22 February 2022

Quick facts

Lead sponsor	D.med Consulting GmbH
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	8
Start date	19 January 2022
Primary completion	22 January 2022
Estimated completion	22 February 2022
Sites	1 location across North Macedonia

Drugs / interventions tested

Convergence Dialyzer

Conditions studied

Renal Dialysis — all drugs for Renal Dialysis →

Sponsor

D.med Consulting GmbH

Who can join

Adults 18 to 85, any sex, with Renal Dialysis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this clinical trial will be to verify the feasibility of using an impeller system instead of a roller pump for hemodialysis, using the established 4008 hemodialysis system and a Convergence Dialyzer with design changes made to the FX-Coral P 600 dialyzer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Renal Dialysis

Currently open trials in the same condition.

NCT06742827 — Educational Intervention and Adherence · NA · active not recruiting
NCT06568835 — The Effect of Active Exercise on Maintenance Haemodialysis Patients · NA · recruiting
NCT06584734 — Effect of Intradialytic Exercise on Left Ventricular Diastolic Function in Hemodialysis Patients · NA · active not recruiting
NCT05755503 — Toxicokinetics of Protein-bound Uremic Toxins in ESRD Patients · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05217095 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by D.med Consulting GmbH
Last refreshed: 2 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05217095.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing